Lördag 21 December | 18:17:23 Europe / Stockholm

Prenumeration

Filter arrow-icon
Språk arrow-icon
2024-11-15 15:30:00
Occlutech Q3 2024 Performance Update: Strong Growth & Increased Efficiency
Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 80 countries and the global addressable market for congenital and structural heart devices provides a significant growth opportunity
2024-08-15 08:00:00
Occlutech Q2 Update: Strong Growth, Efficiency, and Strategic Execution
Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a significant growth opportunity
2024-05-28 08:00:00
Q1 2024 Performance Update: A Strong Start to the Year
Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a significant growth opportunity
2024-03-05 15:05:00
Occlutech Q4 2023 - key approval in the US, solid progress in clinical study and continued strong growth
Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a significant growth opportunity